Thursday, November 19, 2026 • 03:13 AM
AstraZeneca Bets $1.5 Billion on AI to Discover New Liver and Heart Treatments Drug Discovery and Development
AstraZeneca Bets $1.5 Billion on AI to Discover New Liver and Heart Treatments

By Editorial Panel, Editor, Pharma Business Outlook

Pfizer Ends Development of Weight Loss Pill After Liver Safety Concern Clinical Trial Management
Pfizer Ends Development of Weight Loss Pill After Liver Safety Concern

By Editorial Panel, Editor, Pharma Business Outlook

When AI Joins the Drug Discovery Lab Drug Discovery and Development
When AI Joins the Drug Discovery Lab

By Editorial Panel, Editor, Pharma Business Outlook

Walmart Gives Its Pharmacies a Bigger Role in Everyday Health Pharmacy Management
Walmart Gives Its Pharmacies a Bigger Role in Everyday Health

By Editorial Panel, Editor, Pharma Business Outlook

The Pharmacy Becomes a New Front Door for Chronic Care Pharmacy Management
The Pharmacy Becomes a New Front Door for Chronic Care

By Editorial Panel, Editor, Pharma Business Outlook

Leqembi Iqlik Brings Alzheimer’s Treatment Closer to Home Bio Pharma
Leqembi Iqlik Brings Alzheimer’s Treatment Closer to Home

By Editorial Panel, Editor, Pharma Business Outlook

Three-Drug Approach Brings New Hope for HIV Treatment in Newborns Drug Discovery and Development
Three-Drug Approach Brings New Hope for HIV Treatment in Newborns

By Editorial Panel, Editor, Pharma Business Outlook

Post-Surgery Pain Drug Pipeline Gains Momentum as 45 Companies Advance New Treatments Drug Discovery and Development
Post-Surgery Pain Drug Pipeline Gains Momentum as 45 Companies Advance New Treatments

By Editorial Panel, Editor, Pharma Business Outlook

CVS Health Expands Weight Management Services with Easier Access and Personalized Care Pharmacy Management
CVS Health Expands Weight Management Services with Easier Access and Personalized Care

By Editorial Panel, Editor, Pharma Business Outlook

Combination Therapy Shows Promise for Better Allergy Relief Clinical Trial Management
Combination Therapy Shows Promise for Better Allergy Relief

By Editorial Panel, Editor, Pharma Business Outlook

AI Powers the Next Wave of Drug Discovery as Bristol Myers Squibb Expands NVIDIA Partnership Drug Discovery and Development
AI Powers the Next Wave of Drug Discovery as Bristol Myers Squibb Expands NVIDIA Partnership

By Editorial Panel, Editor, Pharma Business Outlook

Expanding Care Closer to Home as NYU Langone Strengthens South Florida Network Integrated Healthcare
Expanding Care Closer to Home as NYU Langone Strengthens South Florida Network

By Editorial Panel, Editor, Pharma Business Outlook

Icosagen Expands Biologics Campus to Speed Up Drug Discovery and Manufacturing Drug Discovery and Development
Icosagen Expands Biologics Campus to Speed Up Drug Discovery and Manufacturing

By Editorial Panel, Editor, Pharma Business Outlook

AI-Designed Lung Disease Drug Reaches Major Milestone with Phase III Trial Drug Discovery and Development
AI-Designed Lung Disease Drug Reaches Major Milestone with Phase III Trial

By Editorial Panel, Editor, Pharma Business Outlook

Lilly and Abbisko Join Forces to Accelerate the Future of Drug Discovery Drug Discovery and Development
Lilly and Abbisko Join Forces to Accelerate the Future of Drug Discovery

By Editorial Panel, Editor, Pharma Business Outlook

Premier Health Charts a Path Through Compliance Challenges Clinical Trial Management
Premier Health Charts a Path Through Compliance Challenges

By Editorial Panel, Editor, Pharma Business Outlook

Pharma Business Outlook

Pharma Business Outlook is more than just a publication—it is a bridge that connects pharmaceutical companies, healthcare providers, and key decision-makers. By fostering discussions on regulatory compliance, emerging market opportunities, and digital transformation, the magazine plays a crucial role in shaping the future of the pharmaceutical ecosystem.